Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes

Clinical Cancer Research

Volumn 17, Issue 9, 2011, Pages 2955-2966

  Su, Hua ^a   Hu, Nan ^a   Yang, Howard H ^a   Wang, Chaoyu ^a   Takikita, Mikiko ^a   Wang, Quan Hong ^c   Giffen, Carol ^b   Clifford, Robert ^a   Hewitt, Stephen M ^a   Shou, Jian Zhong ^d   Goldstein, Alisa M ^a   Lee, Maxwell P ^a   Taylor, Philip R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c SHANXI CANCER HOSPITAL   (China)

^d CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APC2 GENE; ARTICLE; BTC GENE; C10ORF116 GENE; CANCER STAGING; CD3EAP GENE; CD48 GENE; CDC25B GENE; CNN3 GENE; COL1A2 GENE; COL3A1 GENE; COL7A1 GENE; CONTROLLED STUDY; CRCT1 GENE; CST1 GENE; CSTA GENE; CSTB GENE; CXCL10 GENE; DOWN REGULATION; DUSP5 GENE; ECG2 GENE; EGR1 GENE; EMP1 GENE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EVPL GENE; FADD GENE; FEMALE; FOSL2 GENE; FSCN1 GENE; GAPDH GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HEMGN GENE; HLA B GENE; HPGD GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KLK11 GENE; KLK13 GENE; KRT14 GENE; KRT4 GENE; LAMC2 GENE; MAJOR CLINICAL STUDY; MALE; MET GENE; ONCOGENE; PPL GENE; PRIORITY JOURNAL; PRR4 GENE; RARB GENE; REAL TIME POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; S100A9 GENE; SASH1 GENE; SLURP1 GENE; SPARC GENE; SPINK5 GENE; SPINK7 GENE; SPRR1A GENE; TAGLN2 GENE; TGM3 GENE; TISSUE MICROARRAY; UPK1A GENE; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROARRAY ANALYSIS; MICRODISSECTION; MIDDLE AGED; PHENOTYPE; PROGNOSIS;

EID: 79955495946     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-2724     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005;14:243-50.
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
4. Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009. (Pubitemid 35461656)
5. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 2001;98:9754-9. (Pubitemid 32769376)
6. Tamoto E, Tada M, Murakawa K, Takada M, Shindo G, Teramoto K, et al. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 2004;10:3629-38. (Pubitemid 38697596)
7. Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Yanaga K, et al. Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma. Cancer Res 2003;63:5159-64. (Pubitemid 37022658)
8. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001;98:13790-5. (Pubitemid 33115977)
9. Selaru FM, Zou T, Xu Y, Shustova V, Yin J, Mori Y, et al. Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 2002;21: 475-8. (Pubitemid 34123809)
10. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res 2001;7:3519-25. (Pubitemid 33069989)
11. Kan T, Shimada Y, Sato F, Maeda M, Kawabe A, Kaganoi J, et al. Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 2001;286:792-801. (Pubitemid 32912957)
12. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001;7:2213-21. (Pubitemid 32751617)
13. Wu M, Hu N, Wang XQ. Genetic factor in the etiology of esophageal cancer and the strategy of its prevention in high-incidence areas of North China. In:Lynch H.T. and, Hirayama T.editors. Genetic Epidemiology for Cancer. Boca Raton, FL: CRC Press Inc; 1989. p. 187-200.
14. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, et al. Familial aggregation of esophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol 1992;21:877-82. (Pubitemid 23366729)
15. Hu N, Li WJ, Su H, Wang C, Goldstein AM, Albert PS, et al. Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev 2003;27:132-8. (Pubitemid 36429593)
16. Li WJ, Hu N, Su H, Wang C, Goldstein AM, Wang Y, et al. Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma. Oncogene 2003;22:314-8. (Pubitemid 36174189)
17. Hu N, Wang C, Su H, Li WJ, Emmert-Buck MR, Li G, et al. High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high-risk Chinese population. Genes Chromosomes Cancer 2004;39:205-16. (Pubitemid 38209581)
18. Su H, Hu N, Shih J, Hu Y, Wang QH, Chuang EY, et al. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003;63:3872-6. (Pubitemid 36917896)
19. Affymetrix. Genechip expression analysis technical manual. Santa Clara, CA: Affymetrix[cited 2001]. Available from:http://www.affymetrix. com/support/index.affx.
20. Shou JZ, Hu N, Takikita M, Roth MJ, Johnson LL, Giffen C, et al. Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China. Cancer Epidemiol Biomarkers Prev 2008;17:1424-35.
21. Fred Hutchinson Cancer Research Center. Bioconductor-open source software for bioinformatics[cited 2011]. Available from: http://www.bioconductor.org/.
22. Sato T, Iizuka N, Hamamoto Y, Yoshino S, Abe T, Takeda S, et al. Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. Int J Oncol 2006;28:1043-55.
23. Yamabuki T, Daigo Y, Kato T, Hayama S, Tsunoda T, Miyamoto M, et al. Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas. Int J Oncol 2006;28:1375-84.
24. Uchikado Y, Inoue H, Haraguchi N, Mimori K, Natsugoe S, Okumura H, et al. Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. Int J Oncol 2006;29:1337-47.
25. Wong FH, Huang CY, Su LJ, Wu YC, Lin YS, Hsia JY, et al. Combination of microarray profiling and protein-protein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma. Int J Oncol 2009;34:117-28.
26. Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 2009;8:36-46.
27. Zhang X, Zhi HY, Zhang J, Wang XQ, Zhou CN, Wu M, et al. [Expression of annexin II in human esophageal squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi 2003;25:353-5.
28. Luo A, Kong J, Hu G, Liew CC, Xiong M, Wang X, et al. Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 2004;23:1291-9. (Pubitemid 38297184)
29. Lee DG, Bell SP. ATPase switches controlling DNA replication initiation. Curr Opin Cell Biol 2000;12:280-5. (Pubitemid 30265055)
30. Erickson HS, Gillespie JW, Emmert-Buck MR. Tissue microdissection. Methods Mol Biol 2008;424:433-48.
31. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003;162:69-80. (Pubitemid 36041990)
32. Grothey A, Hashizume R, Sahin AA, McCrea PD. Fascin, an actinbundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000;83: 870-3.
33. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003;88:537-47. (Pubitemid 36363363)
34. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-70. (Pubitemid 39551711)
35. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 2006;6:296.
36. Tanière P, Martel-Planche G, Maurici D, Lombard-Bohas C, Scoazec JY, Montesano R, et al. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol 2001;158:33-40. (Pubitemid 32096468)
37. Chung JY, Braunschweig T, Hu N, Roth M, Traicoff JL, Wang QH, et al. A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1403-8. (Pubitemid 44125301)